Rieter (RIEN) H2 2025 earnings summary

Executive summary

• Sales declined 20% year-over-year to CHF 685.1 million, with order intake down 3% to CHF 703.4 million, reflecting cyclical market weakness, lower yarn margins, and volatile investment sentiment.

• Operating EBIT dropped to CHF 2.5 million from CHF 33.9 million in 2024, supported by cost management but impacted by significant restructuring and transaction costs.

• Net result swung to a loss of CHF 63.4 million, impacted by CHF 54.2 million in restructuring, transaction, and impairment effects.

• Strategic flexibility preserved, portfolio strengthened, and positioned for earnings recovery as demand normalizes, with successful Barmag acquisition expanding presence in man-made fibers.

• Leadership changes followed the acquisition, with Georg Stausberg joining the executive committee.

Financial highlights

• Sales: CHF 685.1 million, down 20% year-over-year; order intake: CHF 703.4 million, down 3% year-over-year in CHF, slightly up in local currency.

• Operating EBIT: CHF 2.5 million, down from CHF 33.9 million in 2024.

• Free cash flow: -CHF 40.6 million, compared to +CHF 14.1 million in 2024.

• Net liquidity improved to CHF 184.3 million, supported by capital increase ahead of Barmag closing.

• Shareholders' equity rose 90% to CHF 780.6 million; equity ratio at 53.3% year-end.

Outlook and guidance

• 2026 expected as a transition year with sales guidance of CHF 1.3–1.5 billion and operating EBIT margin of 0%–3%.

• Medium-term scenarios: low market sales CHF 1.4 billion (EBIT margin 2%–5%), mid-market CHF 1.8 billion (5%–8%), high market CHF 2.2 billion (8%–11%).

• Synergy target of CHF 20 million from Barmag integration, with full benefits expected by 2027.

• Capital allocation focused on deleveraging; long-term ambition is net cash position.

• No dividend proposed for the year.